Lifevantage Shares Outstanding 2010-2024 | LFVN

Lifevantage shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Lifevantage Annual Shares Outstanding
(Millions of Shares)
2024 13
2023 13
2022 13
2021 14
2020 15
2019 15
2018 14
2017 14
2016 15
2015 14
2014 16
2013 18
2012 17
2011 10
2010 8
2009 6
Lifevantage Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 13
2024-06-30 13
2024-03-31 13
2023-12-31 13
2023-09-30 13
2023-06-30 13
2023-03-31 13
2022-12-31 13
2022-09-30 12
2022-06-30 13
2022-03-31 13
2021-12-31 13
2021-09-30 13
2021-06-30 14
2021-03-31 14
2020-12-31 14
2020-09-30 15
2020-06-30 15
2020-03-31 15
2019-12-31 15
2019-09-30 15
2019-06-30 15
2019-03-31 15
2018-12-31 15
2018-09-30 15
2018-06-30 14
2018-03-31 14
2017-12-31 14
2017-09-30 14
2017-06-30 14
2017-03-31 14
2016-12-31 14
2016-09-30 14
2016-06-30 15
2016-03-31 14
2015-12-31 14
2015-09-30 14
2015-06-30 14
2015-03-31 14
2014-12-31 14
2014-09-30 15
2014-06-30 16
2014-03-31 15
2013-12-31 16
2013-09-30 18
2013-06-30 18
2013-03-31 18
2012-12-31 18
2012-09-30 18
2012-06-30 17
2012-03-31 15
2011-12-31 17
2011-09-30 17
2011-06-30 12
2011-03-31 10
2010-12-31 13
2010-09-30 13
2010-06-30 9
2010-03-31 8
2009-12-31 8
2009-09-30 8
2009-06-30 7
2009-03-31 4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.175B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Pro-Dex (PDEX) United States $0.140B 27.95